DO WE NEED TO BOTHER MEASURING BONE PROLIFERATION IN AXIAL SpA? INSIGHTS FROM CLINICAL TRIALS

被引：0
|
作者：
Baraliakos, X. [1 ]
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
INV27
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [21] Why do we need noncommercial, investigator-initiated clinical trials?
    Tyndall, Alan
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : 354 - 355
  • [22] Outcome assessment for clinical trials: How many adjudicators do we need?
    Walter, SD
    Cook, DJ
    Guyatt, GH
    King, D
    Troyan, S
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (01): : 27 - 42
  • [23] Do we need randomized clinical trials in extracorporeal respiratory support? Yes
    Alain Combes
    Antonio Pesenti
    Daniel Brodie
    [J]. Intensive Care Medicine, 2017, 43 : 1862 - 1865
  • [24] What do we know from clinical trials?
    Pellock, JM
    [J]. EPILEPSIA, 2005, 46 : 41 - 41
  • [25] Hop, Skip, and Jump Do We Need Phase II Cardiovascular Clinical Trials?
    O'Connor, Christopher M.
    [J]. JACC-HEART FAILURE, 2015, 3 (03)
  • [26] Clinical trials: do we need criteria for pre-study feasibility assessment?
    Maas, Andrew I. R.
    [J]. ACTA NEUROCHIRURGICA, 2016, 158 (11) : 2045 - 2046
  • [27] Contemporary roles of registries in clinical cardiology: when do we need randomized trials?
    Ieva, Francesca
    Gale, Chris P.
    Sharples, Linda D.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (12) : 1383 - 1386
  • [28] DO WE NEED A NEW END-POINT IN CLINICAL-TRIALS TODAY
    GANZ, PA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (14) : 1105 - 1106
  • [29] Clinical trials: do we need criteria for pre-study feasibility assessment?
    Andrew I. R. Maas
    [J]. Acta Neurochirurgica, 2016, 158 : 2045 - 2046
  • [30] Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?
    Guapillo, Carolina
    Hernandez-Pando, Rogelio
    Alberto Flores-Valdez, Mario
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (05) : 1193 - 1195
12345